TINS: Technology Innovation Studio的封面图片
TINS: Technology Innovation Studio

TINS: Technology Innovation Studio

商务咨询服务

Cambridge,Massachusetts 538 位关注者

A New Model Of Innovation

关于我们

The “Technology Innovation Studio (TINS)" is a physical space at the Cambridge Innovation Center (CIC) in Kendall Square that brings together business leaders, scientists and researchers, serial entrepreneurs, angel/VC investors, industry experts, corporate innovation teams and also policy experts to explore and apply tools, methods and models in innovation.

网站
https://tins.world
所属行业
商务咨询服务
规模
2-10 人
总部
Cambridge,Massachusetts
类型
私人持股
创立
2024

地点

TINS: Technology Innovation Studio员工

动态

  • 查看TINS: Technology Innovation Studio的组织主页

    538 位关注者

    Last week, we had the honor of hosting Sean Gilbert, Managing Director of MIT Singapore/Asia programs at Massachusetts Institute of Technology, along with some of his students. This event is part of Singapore’s broader initiative, led by Singapore Global Network (SGN) 's Regional Director (America), Cheryl Lee, to strengthen global connections by fostering meaningful and lasting relationships with Singaporeans, their friends, and partners worldwide. Sean shared insights on how MIT's MIT International Science & Technology Initiatives (MISTI) program, a key initiative within the MIT Center for International Studies (CIS), continues to empower students with over 1,500 global internships, teaching, and research opportunities across 75+ countries annually. With a focus on AI, Climate & Sustainability, Healthcare, and Social Impact, MISTI connects students with cutting-edge research, industry leaders, and global challenges. The program is rapidly growing, with 170 AI internships spanning 20 countries and exciting new collaborations, including plans for the MIT MISTI ASEAN hub in Singapore. From startups to multinational firms, MISTI bridges the gap between innovation and real-world application. It was inspiring to hear directly from his students (Anne C., Kevin Jiang, Vy Pham, Enyu Zhu, and Belinda Vela) about their experiences and their excitement for their upcoming visit to Singapore this summer. Sean's talk was followed by startup showcases featuring fellow Singaporean founders, including Thiri Shwesin Aung - (Founder & CEO), and Jay M. A. (Co-Founder & COO) at Global Impact Assessment presenting Nyxion, as well as Suman Lal (CEO) of Theromics Inc. We're planning another event in mid-April—stay tuned! ??? #SGN #TINS #MIT #MISTI #GlobalImpact #AI #Innovation

    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
      +9
  • ?? We’re excited to announce that the second panel discussion from the QIG will take place early next month! ?? ?? Topic: Quantum Computing – Pioneering the Future of Innovation ??? Date: April 2nd, 2025 ?? Time: 5:00 - 8:00 PM ?? Location: CIC (Cambridge Innovation Center), One Broadway – Venture Cafe, Level 5 ?? During this session we will how quantum computing is revolutionizing the pharmaceutical industry Our keynote speaker, Nash Palaniswamy, will explore the latest trends and breakthroughs in quantum computing. Following the keynote, Nash will join a distinguished panel of experts from both the quantum computing and pharmaceutical sectors to discuss how quantum computing is transforming drug discovery, accelerating development, and unlocking new possibilities in medicine. Our panelists include Andrea de Souza - Chief Corporate Development Officer at Qubit Pharmaceuticals, Rohit A. - Innovation Lead - Novo Nordisk Bio Innovation Hub, Christophe Jurczak - Managing Director at Quantonation, and Will Oliver - MIT Professor & Director, Center for Quantum Engineering, and the discussion will be moderated by Larissa Bifano - US Chair, Patent Development & Strategy practice at DLA Piper. This event is organized by Qubit Pharmaceuticals and hosted by TINS: Technology Innovation Studio, with a big thanks to DLA Piper for making it all possible! ?? Mark your calendar ??, RSVP: https://lu.ma/k7qk7ja4 Sara Dolcetti, Sarada Loock, Salma B., Asma Bensalem #QuantumInterestGroup #QIG #QuantumComputingApplication #InnovativeSolutions #DrugDiscovry #TINS #CIC

  • Whether you are a Singaporean living abroad, someone considering a move to Singapore or just curious to find out more about the opportunities in Singapore, join us at CIC on Monday, March 10, for a get-together event organized by Singapore Global Network (SGN). Cheryl Lee, the general director of SGN will begin the event with her opening remarks. The program then will feature a talk by our guest speaker Sean Gilbert, the managing director of MIT-Asia Pacific Programs at Massachusetts Institute of Technology, followed by a startup showcase. Sean Gilbert is the Managing Director of the MIT-China, MIT-Singapore, and MIT-Australia & New Zealand Programs, overseeing projects across the Asia-Pacific region with MIT students, faculty, and partners. He founded the Singapore (2002) and Australia & New Zealand (2013) programs and is expanding initiatives in Southeast Asia, including launching a MISTI Global Teaching Labs initiative in Vietnam in 2025. Sean also leads the Center for International Studies' Asia regional program and the MISTI AI Impact Area. Before MIT, he co-founded EcoTrends International in Taipei and worked in Taiwan’s Panvest Group and in reinsurance in New York. Sean holds a Master's in Chinese Studies from Princeton University and a Bachelor's in East Asian Studies from New York University. He was born in England, raised in Australia and New York. We look forward to seeing you there! RSVP: https://lu.ma/wh3ih9p9

  • We look forward to our next Wednesday's fireside chat session, tailored for current and aspiring biotech leaders. In this session, Nimita Dave, Director of Clinical Pharmacology and Clinical Operations at LAPIX Therapeutics will engage in a insightful discussion with Jeb Keiper - the CEO of Nimbus Therapeutics, who will share his journey and the strategies he employed to successfully navigate the challenging path from innovation to market leadership. Jeb Keiper is an experienced biotech executive who currently leads Nimbus, where he has driven the discovery and development of multiple programs into clinical testing, raised over $400M in funding, and secured deals totaling over $7 billion. Prior to Nimbus, he was Vice President of Business Development at GSK Oncology, overseeing key collaborations, including the Novartis-GSK Oncology integration. He began his career as a pharmaceutical chemist at Pfizer and also worked as consultant at McKinsey & Company. Jeb brings wealth of knowledge and extensive expertise from the Pharma industry, so you won’t want to miss this event! This event is organized by MIT Management Healthcare Club, hosted by TINS: Technology Innovation Studio, and generously sponsored by Nimbus Therapeutics. ?? Feb 5, 2025 ? 5.30-7.30 EST ?? CIC Cambridge @ 1 Broadway, level 5 ? RSVP link: https://lu.ma/tm17kcpd #BiotechLeadership #Innovation #LeadershipDevelopment #FiresideChat #BiotechCommunity #Networking #FutureLeaders #TINS #CIC

    • 该图片无替代文字
  • We were honored to have Daron Acemoglu, Institute Professor at Massachusetts Institute of Technology and the 2024 Nobel Prize laureate in Economics, with us at the TINS: Technology Innovation Studio last Wed. During his enlightening talk, Professor Daron focused on how AI influences productivity, inequality, and labor markets while also examining the disruptive challenges and opportunities AI presents. Drawing from his co-authored work, Power and Progress: Our Thousand-Year Struggle Over Technology and Prosperity, he provided a cautiously optimistic perspective on our shared future. Productivity and Inequality Acemoglu observed that expectations for AI-driven productivity growth might be overstated. Only around 5% of U.S. businesses currently use AI, despite the United States having been a major player in digitalization since the 1960s. This era saw a huge surge in patent filings, yet the Total Factor Productivity (TFP) growth has been disappointing. Acemoglu also noted that the prevailing vision of AI as “autonomous machine intelligence” often channels technological development toward automation, which generates significant adverse consequences for distribution and wages. Labor Market Implications He highlighted that while 19.9% of tasks are estimated to be exposed to AI, only 23% of those are profitable to automate. This translates to merely 4.6% of tasks feasibly being automated within the next decade. Consequently, the estimated GDP growth from AI in the same period is just 1.16%. These figures call into question more dramatic projections about AI’s ability to overhaul the labor market. Challenges Ahead Acemoglu warned of the dangers of relying too heavily on AI for information, emphasizing the potential loss of collective social learning—one of humanity’s most distinctive traits. He posed critical questions such as: if everyone depends on large language models for knowledge, who will produce genuinely new insights? Even more troubling is the erosion of academic independence in AI research, which is increasingly overshadowed by corporate influence and driven by market incentives that do not necessarily align with the public good. Promises and a Path Forward Despite these concerns, Acemoglu still sees hope in adopting more targeted AI models that prioritize pro-human agency. He briefly referenced early visionaries like Norbert Wiener and JCR Licklider, whose ideas remind us that technology can—and should—augment human abilities rather than replace them. A huge thanks to Ercan A. & Hazal Uzunkaya-Pearson from the Turkish Hub, M.Emin TORUNOGLU and all the sponsors: US Lab Partners LLC, and ERD Metal INC for helping make this event possible. We also extend our gratitude to Timothy Rowe for the opening note and CIC (Cambridge Innovation Center) for their ongoing support of community engagement in technology and innovation. TINS: Technology Innovation Studio remains committed to fostering conversations that shape the forefront of deep tech.

    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
      +1
  • Happy Tuesday! It's almost Feb…. We are excited to share that "Leading Through Innovation: Path to a Successful Biotech CEO", will be taking place on the 5th of Feb. Join us for an exclusive fireside chat tailored for current and aspiring biotech leaders. In this session, Jeb Keiper, CEO of Nimbus Therapeutics will share his journey and the strategies he used to successfully navigate the challenging path from innovation to market leadership. This event is organized by Nimita Dave and hosted by TINS: Technology Innovation Studio. Date: 02/05/2025 Location: CIC @ One Broadway, Cambridge, 02142 Venue: Santo Domingo (Level 5) Registration Link: https://lu.ma/tm17kcpd

  • As the year draws to a close, we want to take a moment to express our heartfelt gratitude for your continued collaboration and support. It’s been a true pleasure working alongside you, and together we’ve made meaningful strides in driving innovation and sparking insightful events, interaction over the past few months. In just six months since its launch, TINS: Technology Innovation Studio has hosted over 30 curated events with renowned speakers and invited attendees, and carried out more than?15 innovation tours for international delegations, startups, regional representatives, and executives. TINS also conducted 8 virtual coaching sessions on fundraising, and supported new product developments in the area of healthcare. We also had the pleasure of supporting the soft landing of international startups as they were looking to establish their presence in Boston. We organized hackathons in international locations in collaboration with MIT Hacking Medicine, and successfully executed on consulting projects with major corporations such as The Coca-Cola Company and universities such as UMass Boston. The most exciting program for us though was the graduation of our scholars from the Summer Immersion Program (LITE), aimed to provide an enriching experience for high-school and college students in an immersive innovation environment. Our partnerships with leading institutions, such as CIC (Cambridge Innovation Center) and Venture Café Cambridge have been instrumental in enabling our efforts to serve partners, collaborators and customers. With over 25 years as an anchor of Boston’s innovation ecosystem, CIC continues to serve as a platform where organizations like TINS can be born and developed to serve the broader community. A special thanks to Timothy Rowe, founder and CEO of CIC and Nathan Plummer, GM of the Venture Cafe Global Institute and the respective teams for their wholehearted support for TINS. Last but not least, a heartfelt thank you to the entire TINS team for making this work possible. We wish you all a very Merry Christmas and a New Year filled with joy, success, and new opportunities. May 2025 bring fresh ideas, exciting ventures, and continued growth for you and your team! Thank you for being a part of our journey this year. We look forward to building on our partnership and exploring new horizons together in the year ahead! #MerryChristmas #HappyNewYear2025 #Innovation #Growth #LookingAhead #CIC #VCC #TINS

    • 该图片无替代文字
  • Did you know that TINS: Technology Innovation Studio, based at CIC (Cambridge Innovation Center), can assist you with space for your large-scale meeting or event in Kendall Square, Cambridge, MA? We also can offer event logistics support, including promoting your event to our network, if so desired.? We helped provide space for Solace’s annual company offsite recently.? Solace is working to make spirituality more digitally accessible to more people through an AI-powered spiritual engagement platform.? Read more about them and sign up for their VIP / Beta Launch preview on their website, https://solace-vr.com.

    • 该图片无替代文字
    • 该图片无替代文字

相似主页

查看职位